SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3194682289> ?p ?o ?g. }

Showing items 1 to 100 of ±185 with 100 items per page.

W3194682289 endingPage "301" @default.
W3194682289 startingPage "283" @default.
W3194682289 abstract "Ovarian cancer is one of the leading causes of cancer-related mortality in women. The treatment of ovarian cancer consists of surgical removal of vast majority of the tumor mass followed by chemotherapy, hormone therapy, and/or radiotherapy of the remaining mass and metastases. A variety of chemotherapeutic drugs have been used in gynecologic cancers either alone or in combination therapy such as cisplatin, carboplatin, paclitaxel, docetaxel, doxorubicin, cyclophosphamide, gemcitabine, topotecan, and vinorelbine. Even though the combination therapy has a 70% response rate, tumor relapse and subsequent chemoresistance are frequently observed, eventually resulting in treatment failure and mortality in majority of the patients. Chemoresistance can be intrinsic or acquired through various cellular modifications, and drugs targeting these systems can overcome the chemoresistance and hopefully extend patient survival. Targeted therapy is a relatively new treatment approach where the drugs attack the oncogenic pathways in the malignant cells. Targeted therapy is designed to selectively target the molecules and mechanisms that cause chemoresistance and eliminate them so that chemotherapeutic drugs can work to their full potential of antitumor activity. Since these pathways are associated with chemoresistance, targeting them could help sensitize the malignant cells to standard chemotherapy drugs. Some of the drugs include efflux pump inhibitor, tariquidar, tyrosine kinase inhibitors such as erlotinib and gefitinib, and PARP inhibitors such as olaparib, veliparib, and p53 inhibitors. This research chapter discusses in detail about the current targets and related drugs for better management of patients with ovarian cancer and improved quality of life." @default.
W3194682289 created "2021-08-30" @default.
W3194682289 creator A5001716364 @default.
W3194682289 creator A5023616881 @default.
W3194682289 creator A5040010155 @default.
W3194682289 creator A5067022259 @default.
W3194682289 creator A5080109333 @default.
W3194682289 creator A5087877279 @default.
W3194682289 date "2021-01-01" @default.
W3194682289 modified "2023-10-18" @default.
W3194682289 title "Ovarian cancer: Targeted therapies and mechanisms of resistance" @default.
W3194682289 cites W1582164157 @default.
W3194682289 cites W1796241146 @default.
W3194682289 cites W192654233 @default.
W3194682289 cites W1964137986 @default.
W3194682289 cites W1964359203 @default.
W3194682289 cites W1965392734 @default.
W3194682289 cites W1965568527 @default.
W3194682289 cites W1966889884 @default.
W3194682289 cites W1968807523 @default.
W3194682289 cites W1971579914 @default.
W3194682289 cites W1974693247 @default.
W3194682289 cites W1976816133 @default.
W3194682289 cites W1981219604 @default.
W3194682289 cites W1989991921 @default.
W3194682289 cites W1996193504 @default.
W3194682289 cites W1999659639 @default.
W3194682289 cites W2000402876 @default.
W3194682289 cites W2000590092 @default.
W3194682289 cites W2007844506 @default.
W3194682289 cites W2009971333 @default.
W3194682289 cites W2011122139 @default.
W3194682289 cites W2011206688 @default.
W3194682289 cites W2020850506 @default.
W3194682289 cites W2024411346 @default.
W3194682289 cites W2025412572 @default.
W3194682289 cites W2025549254 @default.
W3194682289 cites W2026147693 @default.
W3194682289 cites W2028415754 @default.
W3194682289 cites W2028662865 @default.
W3194682289 cites W2029604570 @default.
W3194682289 cites W2033346155 @default.
W3194682289 cites W2033816200 @default.
W3194682289 cites W2034687480 @default.
W3194682289 cites W2039832404 @default.
W3194682289 cites W2042633087 @default.
W3194682289 cites W2043230719 @default.
W3194682289 cites W2046592303 @default.
W3194682289 cites W2052266277 @default.
W3194682289 cites W2055397209 @default.
W3194682289 cites W2060555106 @default.
W3194682289 cites W2060756680 @default.
W3194682289 cites W2064065563 @default.
W3194682289 cites W2072767112 @default.
W3194682289 cites W2075668200 @default.
W3194682289 cites W2075879528 @default.
W3194682289 cites W2077422669 @default.
W3194682289 cites W2079171323 @default.
W3194682289 cites W2080943490 @default.
W3194682289 cites W2085739259 @default.
W3194682289 cites W2088561077 @default.
W3194682289 cites W2092440654 @default.
W3194682289 cites W2094666871 @default.
W3194682289 cites W2096293110 @default.
W3194682289 cites W2104812730 @default.
W3194682289 cites W2110017381 @default.
W3194682289 cites W2111437716 @default.
W3194682289 cites W2111452131 @default.
W3194682289 cites W2113214957 @default.
W3194682289 cites W2113689159 @default.
W3194682289 cites W2117964602 @default.
W3194682289 cites W2120806256 @default.
W3194682289 cites W2123206362 @default.
W3194682289 cites W2124295966 @default.
W3194682289 cites W2125100184 @default.
W3194682289 cites W2126273255 @default.
W3194682289 cites W2127039405 @default.
W3194682289 cites W2128746885 @default.
W3194682289 cites W2130103542 @default.
W3194682289 cites W2137373982 @default.
W3194682289 cites W2137760882 @default.
W3194682289 cites W2141458996 @default.
W3194682289 cites W2142134791 @default.
W3194682289 cites W2142795777 @default.
W3194682289 cites W2149159811 @default.
W3194682289 cites W2149441684 @default.
W3194682289 cites W2151509048 @default.
W3194682289 cites W2151783390 @default.
W3194682289 cites W2152550058 @default.
W3194682289 cites W2155191323 @default.
W3194682289 cites W2158573424 @default.
W3194682289 cites W2160466424 @default.
W3194682289 cites W2161817637 @default.
W3194682289 cites W2168752603 @default.
W3194682289 cites W2170728568 @default.
W3194682289 cites W2215562775 @default.
W3194682289 cites W2308659819 @default.
W3194682289 cites W2317055602 @default.